Category: ADvocate 1 & 2 Studies - Medicine Pharmacy Nutrition

No Image

Lilly Reports Results of Lebrikizumab in P-III ADvocate 1 and 2 Studies for the Treatment of Moderate to Severe Atopic Dermatitis

August 16, 2021 Auto Bot 0

Shots: The ongoing P-III ADvocate 1 & 2 studies evaluate lebrikizumab as monothx. vs PBO in adult & adolescent patients aged 12 to less than […]

Copyright © 2022 | WordPress Theme by MH Themes

Azərbaycan dili

Беларуская мова

বাংলা

Български

ქართული

Ελληνικά

ગુજરાતી

Ōlelo Hawaiʻi

עִבְרִית

हिन्दी

Bahasa Indonesia

ಕನ್ನಡ

Қазақ тілі

ភាសាខ្មែរ

Кыргызча

ພາສາລາວ

Latviešu valoda

Lietuvių kalba

Lëtzebuergesch

Македонски јазик

മലയാളം

मराठी

ဗမာစာ

नेपाली

ਪੰਜਾਬੀ

Српски језик

සිංහල

தமிழ்

తెలుగు

Українська